Meatly’s Low-Cost Bioreactor Could Slash Cultivated Meat Production Expenses by 95%

Meatly has successfully developed a pilot-scale bioreactor at a price significantly lower than traditional pharmaceutical-grade bioreactors used in the cultivated meat sector. Priced at around £12,500, this bioreactor has the potential to cut production expenses by up to 95%. The company has also achieved a breakthrough in culture media cost, with expectations to reduce it to as low as 1.5 pence per liter, well below the industry benchmark of £1 per liter.

Traditionally, the cultivated meat industry has faced challenges with expensive bioreactors sourced from the pharmaceutical sector, which are designed to meet strict sterility and regulatory standards. However, Meatly's innovative approach aims to reduce costs and improve commercial viability in the sector. With the recent launch of the world's first pet food containing cultivated meat, Meatly is positioning itself to attain price parity while maintaining high production standards, focusing on regulatory approval for cultivated meat for both pet food and human consumption in the UK.